Week 433 Review - Yet another bad week as the Santa Rally fails to get going.

Lots of drops across the portfolio, with the deficit between cost and value widening by £3,423 to £93,306 and total value at £108,126 

Worst performer was IES:Invinity Energy which seemed to be recovering but has dropped like a stone. This week they fell 15% and are now 87% down.

BLU:Blue Star Capital had another big drop which in combination with last week's drop pretty much wipes out any recent gains.

CWR:Ceres Power lost all last week's gains to drop 7% and go back to a 34% loss.

OPTI:Optibiotix is sliding slowly and fell another 5% this week.

SBTX:SkinBioTherapeutics also fell 5%, which is at least better then the last couple of weeks but still very bad.

JLP:Jubilee Metals had a small recovery of 5% but I'm still losing big on this one.

I hate to say that SAE:Simec Atlantis Energy wins Share of the Week, with a 6% rise. It didn't do much to recover my 89% loss though.

Here's the ISA and shares portfolio after week 17 of year 9.

			Weekly Change
Cash	£165.60		+£0
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£50,946.53	(-48.6%)	-£1,647.16
Potential profits	£2,274.71		-£255.49
Yr 9 Dividends	£147.01		+£0
Yr 9 Interest	£2.46		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£31.15	(0.5%)	-£1.95
Total Dividends	£12,058.44		+£0
Total Interest	£4.39		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£289.78	(4.9%)	-£0.67
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Nothing much to report other than the drop in value and potential profit.

All recent gains have been wiped out.

Well below the rapidly flattening trend line.

The SIPP looks like this after week 417 overall and week 1 of year 9.

			Weekly Change
Cash	£428.33		+£76.51
Portfolio cost	£99,680.94		+£0
Portfolio sell value (bid price - commission)	£55,347.44	(-44.5%)	-£1,779.09
Potential profits	£3,733.31		-£342.04
Yr 9 Dividends	£13.99		+£13.99
Yr 9 Interest	£0		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£0	(0%)	+£0
Total Dividends	£14,648.87		+£13.99
Total Interest	£5.93		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£252.86	(4.5%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

I got a tax rebate and £13 dividend from UKW:Greencoat UK Wind, with drops in value and potential profit for the portfolio.

Not so close to the injection line any more.

Just about staying above the trend line.

The trading account looks like this after week 383 overall and week 19 of year 8.

			Weekly Change
Cash	£141.20		-£140.60
Portfolio cost	£1,935.11		+£140.60
Portfolio sell value (bid price - commission)	£1,097.50	(-43.3%)	+£3.23
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£66.72	(+41.4%)	-£3.71
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.54	(-4.1%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

I was eligible for the retail offer in SBTX:SkinBiotherapeutics so was allowed to buy 740 shares at 19p costing £140.60. I figured it was worth it in my trading account as there's no commission. I very much doubt I'll get a quick reward though, as the share price is dropping down to the retail offer price. Sell value increased by £3 (not including the increase in cost from the purchase)

The green line includes cash, which is why that stayed level as costs went up.

At least it didn't go down...

That's the holiday period caught up - looking forward to reporting on some profits and new purchases at the end of this week.

Week 432 Review - A great week for most shares, but my biggest holdings drop.

It wasn't a bad week for most shares, but some of my biggest holdings fell and so the deficit between cost and value widened by £1,421 to £89,883 and total value dropped to £111,473.

Worst performer was BLU:Blue Star Capital which lost half of last week's inexplicable gains and dropped 18%.

SBTX:SkinBioTherapeutics fell another 13% as my recent investment is decimated.

KIBO:Kibo Energy dropped 10% and I'm sure will never recover from the current 100% loss.

On the brighter side, ASHM:Ashmore Group recovered from an utterly miserable few months by rising 6%, but is still 40% down.

BARC:Barclays also rose 6% but is still 14% down in my trading account.

CEY:Centamin responded to the increase in gold price better than EDV:Endeavour Mining and climbed 6% to go 24% down.

PAGE:Page Group keep flirting with going into profit, and climbed 6% to go only 5% down. Will I be able to bed them into my ISA soon without having to record a paper loss?

ANTO:Antofagasta went up 7% and are now only 9% down so also getting towards profitability.

CAML:Cental Asia Metals are now one of my larger holdings and climbed 7% so my most recent purchase is only 1% down.

CWR:Ceres Power are so volatile, but this week in the right direction as they increased 7%.

III:3i Group have been a rare example of a successful magic formula share, and rose 7% to go 33% up.

Share of the Week is PSN:Persimmon which climbed 8% for no reason I could detect, and are now only 15% down.

Here's the ISA and shares portfolio after week 16 of year 9.

			Weekly Change
Cash	£165.60		-£3.80
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£52,593.69	(-46.9%)	-£1,152.08
Potential profits	£2,530.20		-£256.14
Yr 9 Dividends	£147.01		+£0.11
Yr 9 Interest	£2.46		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£33.10	(0.6%)	-£8.91
Total Dividends	£12,058.44		+£0.11
Total Interest	£4.39		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£290.45	(4.9%)	-£2.07
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Not much going on. The 11p dividend was a fractional sum following the share consolidation at RDT:Rosslyn Data and is probably the only return I will ever get from that investment.

The decline continues

Touching the trend line but not below it

The SIPP looks like this after week 416 overall and week 52 of year 8.

			Weekly Change
Cash	£351.82		-£1.44
Portfolio cost	£99,680.94		+£0
Portfolio sell value (bid price - commission)	£57,126.53	(-42.7%)	-£281.81
Potential profits	£4,075.35		+£4.32
Yr 8 Dividends	£492.10		+£0
Yr 8 Interest	£5.68		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£771.75	(-13.6%)	+£15.01
Total Dividends	£14,634.88		+£0
Total Interest	£5.93		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£253.55	(4.5%)	-£0.62
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Much smaller losses in this account thanks to the gains in other stocks.

Looks nice and flat. Still encouragingly close to the injection line.

Still above the trend line - yippee!

The trading account looks like this after week 382 overall and week 18 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£953.67	(-46.9%)	+£12.65
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£70.43	(+47.1%)	-£4.14
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.56	(-4.4%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

A rare increase in value!

Have we bottomed out?

Still a long way to go to recover.

That's 2 out of 3 weeks caught up. One more to go...

Week 431 Review - Dreadful week as all my large holdings drop

A pretty bad week for almost everything, with the gap between cost and value widening by £3,268 to £88,462 and total value dropping to £112,899.

Worst performer was SBTX:SkinBioTherapeutics which fell 15%, which is deeply upsetting after my recent big purchase.

CWR:Ceres Power has been an utter disaster and fell another 14% to go 33% down in just a few weeks.

JLP:Jubilee Metals is one of my largest holdings and continues to drop, this week by 6% to go below 5p.

SAE:Simec Atlantis Energy also fell 6% for no particular reason.

ANTO:Antofagasta dropped 5% to go 15% down.

EDV:Endeavour Mining also dropped 5% but fortunately my recent purchase is still just in profit.

OPTI:Optibiotix continued to slide with another 5% drop contributing to much of the losses this week.

Only one share rose more than 5% so BLU:Blue Star Capital gets Share of the Week rising 38%, but I suspect it's just shorts closing as there's no reason for it to go up.

Here's the ISA and shares portfolio after week 15 of year 9.

			Weekly Change
Cash	£169.40		+£26.58
Portfolio cost	£99,082.34		+£0
Portfolio sell value (bid price-commission)	£53,745.77	(-45.8%)	-£3,268.08
Potential profits	£2,786.34		-£1,142.87
Yr 9 Dividends	£146.90		+£25.71
Yr 9 Interest	£2.46		+£0.87
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£42.01	(0.7%)	+£6.10
Total Dividends	£12,058.33		+£25.71
Total Interest	£4.39		+£0.87
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£292.52	(5.0%)	-£0.42
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I received a £25 dividend from PLUS:Plus 500 and 87p interest. Big drop in portfolio value and most of reduced potential profits were due to OPTI:Optibiotix.

Hope this doesn't become a trend!

Almost down to the trend line - let's hope we don't cross it

The SIPP looks like this after week 415 overall and week 51 of year 8.

			Weekly Change
Cash	£353.26		+£0.46
Portfolio cost	£99,680.94		+£249.92
Portfolio sell value (bid price - commission)	£57,408.34	(-42.7%)	-£2,542.45
Potential profits	£4,071.03		-£358.24
Yr 8 Dividends	£492.10		+£0
Yr 8 Interest	£5.68		+£0.46
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£786.76	(-13.9%)	+£15.77
Total Dividends	£14,634.88		+£0
Total Interest	£5.93		+£0.46
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£253.95	(4.5%)	-£0.61
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		+0%

Similar story to the ISA except with no dividend. My regular investment went through, purchasing 91 shares in AJB:AJ Bell at 271.6296p costing £249.92. Just one more week to go and I'll be able to wave goodbye to the depressing DDDD:4D Pharma loss haunting me every week for Year 8.

Seems less of a drop than the ISA

A little more of a buffer to the trend line than the ISA

The trading account looks like this after week 381 overall and week 17 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£941.02	(-47.6%)	-£24.21
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£74.57	(+49.9%)	-£4.66
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.57	(-4.4%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Yet another drop. Nothing more to say.

Long term decline.

I'm amazed the trend line isn't flatter by now, but I can't see a £300 reversal in fortune to get back anywhere near it, so it will flatten quickly.

This was a catch up from when I was on hols and managed to take the weekly snapshots. Another 2 weeks of catch-ups to write before we're up to date...

Week 430 Review - A great week ruined by big drops for Optibiotix and Jubilee Metals

Deeply upsetting that over the best couple of days for a long time across my portfolio, big drops in both OPTI:Optibiotix and JLP:Jubilee Metals caused the deficit between cost and value to widen by £7,184 to £82,627 and portfolio value fell to £118,457.

Worst performer was OPTI:Optibiotix which dropped 3p and 9%. I guess after last week's 25% rise it's not a huge surprise, but was so disappointing when everything else was doing so well.

BLU:Blue Star Capital is highly volatile and gave up the 6% rise from last week.

POLY:Polymetal was a surprise, dropping by 6% when other gold miners did well.

JLP:Jubilee Metals is one of my biggest holdings, so a 5% drop this week continues their inexplicable fall. I took the opportunity to buy some more.

Now for the very extensive good news.

BARC:Barclays recovered from last week's 11% drop by climbing 5%, but they are still 18% down.

EDV:Endeavour Mining has been a bit dreadful recently, but also climbed 5% and leaves my recent purchases 9% up.

GAW:Games Workshop slumped recently from their price a few months ago, but a 5% climb this week put my holding 7% up. It's a long way back to the 20% gains I had before their stellar results though.

IGG:IG Group have been drifting horribly, and I still don't understand why. This week they went up 6% but are still 26% down.

IES:Invinity Energy usually needs news to shift the price up, but this week climbed 6% without any. They are still an eye-watering 83% down, but given I thought they would go bust I guess it's a bonus they still exist.

ASHM:Ashmore Group have been drifting for a long time, but bounced back 7% this week. They are 36% down so a long way to go to break even.

CEY:Centamin was my best gold mine this week, climbing 8% but still 27% down.

PAGE:Page Group plummeted after results a few weeks ago, but fought back 12% this week and are now only 12% down. I still have these in my dealing account and want them to get into profit before I bed and ISA them.

PSN:Persimmon have also been really struggling lately, but went up 13% this week and are now 24% down.

WHR:Warehouse REIT have also been really bad lately, but they bounced back 15% and are now 27% down.

Share of the Week is CWR:Ceres Power which has been my worst timed purchase ever, as it has crashed every week since. This week it clawed back 18% of those losses but is still 22% down. Hopefully this will continue, but it's going to take news of their Chinese joint venture being approved to get any meaningful recovery.

Here's the ISA and shares portfolio after week 14 of year 9.

			Weekly Change
Cash	£142.82		-£98.24
Portfolio cost	£99,082.34		+£599.99
Portfolio sell value (bid price-commission)	£57,013.85	(-42.5%)	-£3,377.57
Potential profits	£3,929.21		-£873.20
Yr 9 Dividends	£121.19		+£5.50
Yr 9 Interest	£1.59		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£35.91	(0.6%)	-£2.57
Total Dividends	£12,032.62		+£5.50
Total Interest	£3.52		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£292.94	(5.0%)	-£0.66
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I added £150 following a premium bond win, and topped that up with another £350 and transferred £100 dividends from my dealing account to my ISA. That allowed me to buy 11,135 shares in JLP:Jubilee Metals at 5.299p costing £599.99. It reduced my average price in my AJ Bell ISA to 6.96p, and with that holding containing 66,947 shares, if it gets back to 12p like a few months ago I'll be over £3,000 in profit for that holding. I really think it should be back there before Christmas, but I never expected it to fall this low.

Portfolio value gave up almost half last week's gains thanks to OPTI:Optibiotix and JLP:Jubilee Metals, and potential profits dropped £873 thanks to OPTI:Optibiotix. A £5 dividend from GAW:Games Workshop was nice, if a tad stingy.

I suppose I should expect a bit of a pull back after last week being so great.

Unfortunately we're going back towards the trend line, but happy to be still above it.

The SIPP looks like this after week 414 overall and week 50 of year 8.

			Weekly Change
Cash	£352.80		-£160.87
Portfolio cost	£99,431.02		+£2,408.21
Portfolio sell value (bid price - commission)	£59,700.87	(-40.0%)	-£3,806.93
Potential profits	£4,429.27		-£788.62
Yr 8 Dividends	£492.10		+£14.00
Yr 8 Interest	£5.22		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£802.53	(-14.2%)	+£16.14
Total Dividends	£14,634.88		+£14.00
Total Interest	£5.47		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£254.56	(4.5%)	-£0.65
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	36%		-1%

I had my £2,000 pension transfer to invest this week, so immediately bought 733 shares in CAML:Central Asia Metals at 163.5118p and costing £1,210.49. I'll keep buying more of these while they remain so cheap, as they have no debt, bucket loads of cash, and a massive dividend.

I managed to find a new source of stats for my magic formula spreadsheet, and whacked in the data for the top 170 and ranked them. I had to change a few of the stats I use, but I think they still give a similar impression of the company. I still use dividend yield as the first ranking criteria, but I had to change ROCE to return on investment, and had to change debt to pre-tax profits ratio to debt to equity ratio. Not ideal but still a good impression of the sustainability of their debt. The 3 year growth had to change to 5 year growth, which still gives a good idea of how they are growing, although misses recent good performance if they had a few bad years before that.

When I ranked my top 100 it made quite a few changes, but by far the top company was PLUS:Plus 500 so I bought 69 shares at 1428.6949p costing £997.75. I already hold these, but I think increasing my holding in some of the companies I already know well is better then trying new ones.

SQZ:Serica Energy came 2nd, but I'm not investing in oil companies. IPX:Impax Asset Management Group were 3rd, so I may take a look at those. POLR:Polar Capital Holdings is 4th, and one I have held in the past. HL.:Hargreaves Lansdown is 5th and may be worth a look as I do have an account with them.

Some of my existing holdings are still in the top 10, with III:3i Group 6th and PAGE:Page Group 8th. GAW:Games Workshop is 11th. The others are less impressive, with IGG:IG Group Holdings 22nd and RIO:Rio Tinto 23rd, but both are in the top 30 which is my criteria for keeping them.

CAML:Central Asia Metals is 34th, which isn't too bad, PSN:Persimmon is 43rd, UKW:Greencoat UK Wind 44th, CEY:Centamin 46th, ANTO:Antofagasta 53rd, APAX:Apax Global Alpha 61st, ASHM:Ashmore Group 66th, CAPD:Capital 71st, FXPO:Ferrecpo 79th, WHR:Warehouse REIT 134th and most disappointingly EDV:Endeavour Mining 145th.  

It means I should be selling the companies outside the top 30 and replacing them with companies higher up the ranking, but all of them are making a loss. I will flag them for removal should an opportunity arise.

I also bought 3,586 shares in JLP:Jubilee Metals in my AJ Bell account with some dividend money. I paid 5.299p and they cost £199.97. I don't usually like buying for less than £500 because of the commission, but as I'm adding to my existing holding, the sell commission will be shared and I'm hoping they will go up sharply soon.

I got a £14 dividend from PSN:Persimmon, and value and potential profits are down for the same reasons as the ISA.

Sad to see the green line point down when the red and orange point up.

Sharp drop towards the trend line

The trading account looks like this after week 380 overall and week 16 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£965.23	(-46.2%)	-£0.44
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£79.23	(+53.0%)	-£5.28
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.59	(-4.4%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

BARC:Barclays went up really well but JLP:Jubilee Metals went down, so they cancelled each other out and I lost 44p.

Nice to at least stop the rot.

Way below the trend line which will start to flatten unless I can get back up above it.

What makes this week even more depressing is that the drop in OPTI:Optibiotix came on the back of an encouraging commercial update. Every time I think things are turning round, the price drops yet again, and for my biggest holdings to drop significantly in such a good week is very frustrating.

No blog for the next couple of weeks as I'll be on hols but will aim to get a snapshot each week so I don't lose any stats and can do a bumper catch-up when I get back.

Week 429 Review - One of the best weeks ever.

One of the best ever weeks, with lots of gains across the portfolio, and 25% increases in both OPTI:Optibiotix and SBTX:SkinBioTherapeutics narrowed the gap between cost and value by £17,081 to £75,442 and total portfolio value increased to £122,893.

The worst performer was BARC:Barclays, in a week when all the banks got hammered. They dropped by 11% and left my trading account in a right mess.

IES:Invinity Energy dropped 10%, I suspect as people took profits following the recent rises. I'd hoped they would settle down but looks like they will drift until the next news.

EDV:Endeavour Mining fell 6% which was a surprise given the price of gold has held up during the week. The drop wiped out all of last weeks gains. I'm of a mind to buy some more of these with my pension transfer. If I add another £1,000 that would take my total holding to £2,500 and I could switch my monthly investment to CEY:Centamin which is likely to stay cheaper for longer.

POLY:Polymetal also had a bad week, dropping 5%.

SAE:Simec Atlantis Energy fell 5% but that's not a surprise as it wobbles on the brink of destitution.

Better news for one of my larger holdings CAML:Cental Asia Metals, which climbed 5%. I'm definitely using some of my pension here and build my position towards £10k over time. If JLP:Jubilee Metals ever sorts itself out I'll re-invest profits here.

BLU:Blue Star Capital is up and down like a yo-yo and went up 6% this week.

RIO:Rio Tinto climbed 6%, possibly after positive news about a new joint venture.

PLUS:Plus 500 had a great trading update and went up 10%, but my holding is still 25% down. They have massive amounts of spare cash so I'm hoping for a special dividend.

OPTI:Optibiotix went up 6.5p which accounts for the vast majority of this week's rise, My most expensive holding bought in the 90p range is still down by 64%, but my best holding bought for 9.55p is up by 235%. I could cash in over £8,000 profit if I sold my cheaper shares, but I'm not going to.

Share of the Week is SBTX:SkinBioTherapeutics, which also went up 25% and wins the prize because I'm so happy about the £5k premium bonds I sold to invest in SBTX. That holding is up by 24% after being 1% down last week, and they are making £1,185 potential profit. My other holdings are losing £700, so it means I'm actually up overall on this company. I'd like to think it could climb another 10p before settling, but I won't take profits as this is a long term investment.

Here's the ISA and shares portfolio after week 13 of year 9.

			Weekly Change
Cash	£241.06		-£3.14
Portfolio cost	£98,482.35		+£0
Portfolio sell value (bid price-commission)	£59,791.43	(-39.3%)	+£8,502.03
Potential profits	£4,802.41		+£2,655.30
Yr 9 Dividends	£115.69		+£0
Yr 9 Interest	£1.59		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£38.48	(0.7%)	-£1.24
Total Dividends	£12,027.12		+£0
Total Interest	£3.52		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£293.60	(5.0%)	-£0.04
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Cash dropped due to AJ Bell fees, there's a massive increase in value, and potential profits up thanks to OPTI:Optibiotix and SBTX:SkinBioTherapeutics. My only other profitable share is GAW:Games Workshop, which went up 1%. Long term returns are at 5% which is half my target. I need to make about £28,000 profit to get back to my 10% target. 

That's almost halved the gap between injection amount and value. 

That's more like it. A comfortable gap above the trend line.

The SIPP looks like this after week 413 overall and week 49 of year 8.

			Weekly Change
Cash	£513.67		+£92.31
Portfolio cost	£97,022.81		+£0
Portfolio sell value (bid price - commission)	£61,099.59	(-37.0%)	+£8,643.83
Potential profits	£5,217.89		+£1,610.35
Yr 8 Dividends	£478.10		+£0
Yr 8 Interest	£5.22		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£818.67	(-14.9%)	+£16.93
Total Dividends	£14,620.88		+£0
Total Interest	£5.47		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£255.21	(4.7%)	-£0.63
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Cash went up thanks to a tax rebate, reduced slightly by AJ Bell fees. Similar story to the ISA, with value up by £8,643, but less of a contribution from SBTX:SkinBioTherapeutics as my holding is much smaller. Potential profits up by £1,610 all thanks to OPTI:Optibiotix because my other profitable shares both dropped in value. Long term performance is worse here than my ISA so I'll need even more profits to get to 10%.

So close to the injection line!

Even higher above the trend line than the ISA, but will I ever get back to break even?

The trading account looks like this after week 379 overall and week 15 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£965.67	(-46.2%)	-£64.48
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£84.51	(+56.5%)	-£6.04
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.61	(-4.4%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

In contrast to the good news on my other accounts, this one was a disaster, with BARC:Barclays falling 11% after their results. I was so close to getting into profit just a few weeks ago, but now they are 23% down. JLP:Jubilee Metals also fell 4% this week, so a big £64 loss overall.

That is a very sad sight.

The trend line is still upwards, but will flatten very quickly if I can't make up about £250 to get back on it.

We were told OPTI:Optibiotix is close to signing a deal on the microbiome modulators back in August, the assumption being the people who need to sign it were on holiday, and we would get news in September. It's now nearly November and we've heard nothing, so I do start to worry there's a hitch. As far as I'm aware, if this contract isn't signed then I don't think there are any others in the pipeline, and if we want to see the share price re-rate, there has to be movement on the 2nd generation products, as they hold promise of significantly greater revenue than our 1st generation products.

There's also been silence from PBX:Probiotix. I'm gutted that we're still not incorporated into VSL, as I was expecting that a year ago. There's just no sign of any meaningful new markets. Even if there were signs, it's impossible to trade the shares on Aquis so unless they list on AIM I can't see the share price moving. 5p is a crazy price for what we have. We should at least have remained at the IPO price, but it's going to take a 300% rise for me to get back to break even.

So although this has been a great week, I'm still worried that the share prices on my microbiome companies will drift again unless there's news with revenue attached.

The less said about JLP:Jubilee Metals the better!!

Week 428 Review - Dreadful week but losses not too great.

Another really bad week across the majority of the portfolio. OPTI:Optibiotix remained unchanged but the rest of the portfolio lost £653 as the deficit between cost and value widened to £92,524 and total value dropped to £105,722.

Worst performer was CWR:Ceres Power which has possibly been my worst timed investment ever. It had been creeping up when I bought them, and I took that as a sign of recovery, but they plummeted 19% this week and are 31% down in just a few weeks since I bought them.

BLU:Blue Star Capital fell 11% but I've pretty much written these off so it doesn't matter.

APAX:Apax Global Alpha dropped 7% so have gone from amber to orange as they are now 16% down.

IES:Invinity Energy fell 7% for no reason and are 82% down. I've not written these off, but they need some really big orders to start making a profit.

WHR:Warehouse REIT are one of my magic formula shares and I thought were a nice sensible option, but dropped 7% this week to go 35% down.

ANTO:Antofagasta are another magic formula share which fell 6% to go 13% down.

PAGE:Page Group are yet another magic formula share. They fell 6% to go 18% down, when they were nearly in profit a few weeks ago.

BARC:Barclays are in my trading account so bound to be cursed. They dropped 5% to go 13% down when they looked like going onto profit a few weeks ago.

CEY:Centamin fell 5% despite the price of gold going up and are 29% down.

My other gold shares fared much better, with POLY:Polymetal increasing 5%, although these are still 79% down until they can shed their Russian assets and re-list in UK.

Share of the Week is EDV:Endeavour Mining, which behaved like a proper gold mine share and climbed 6%. My recent, albeit small, holding is now 10% in profit.

Here's the ISA and shares portfolio after week 12 of year 9.

			Weekly Change
Cash	£244.20		+£32.85
Portfolio cost	£98,482.35		+£0
Portfolio sell value (bid price-commission)	£51,289.40	(-47.9%)	-£366.17
Potential profits	£2,147.11		+£8.80
Yr 9 Dividends	£115.69		+£32.85
Yr 9 Interest	£1.59		+£0
Yr 9 Profit from sales	£0		+£0
Yr 9 proj avg monthly profit	£39.72	(0.7%)	+£12.94
Total Dividends	£12,027.12		+£32.85
Total Interest	£3.52		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£293.64	(5.0%)	+£0.34
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Drop in value of £366, but increase in potential profits of £8 thanks to a very small improvement for GAW:Games Workshop. £32 dividend was from CAML:Central Asia Metals. Dividends alone are keeping the year 9 performance in profit.

Not enough of a drop to cause immediate concern

Getting a bit close to the trend line for comfort

The SIPP looks like this after week 412 overall and week 48 of year 8.

			Weekly Change
Cash	£421.36		+£132.45
Portfolio cost	£97,022.81		+£0
Portfolio sell value (bid price - commission)	£52,455.76	(-45.9%)	-£254.82
Potential profits	£3,607.54		-£8.68
Yr 8 Dividends	£478.10		+£132.45
Yr 8 Interest	£5.22		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£835.60	(-15.2%)	+£29.99
Total Dividends	£14,620.88		+£132.45
Total Interest	£5.47		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£255.84	(4.7%)	+£0.77
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

A great week for dividends, with a whopping £95 from CAML:Central Asia Metals and a healthy £37 from IGG:IG Group. Portfolio value hardly dropped at all and potential profits fell £8 thanks a mix of risers and fallers. 

Very flat

Not flat enough!

The trading account looks like this after week 378 overall and week 14 of year 8.

			Weekly Change
Cash	£281.80		+£0
Portfolio cost	£1,794.51		+£0
Portfolio sell value (bid price - commission)	£1,030.15	(-42.6%)	-£32.97
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£0
Yr 8 proj avg monthly profit	£90.55	(+60.6%)	-£6.97
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£0
Average monthly cash profit	-£6.63	(-4.4%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

Everything dropped in value so much misery here.

Down to lowest value fro a few months

Horribly dropped off a cliff.

I keep announcing dreadful weeks, but the portfolio has been relatively resilient. It's as bad as mid summer at the moment, when things are supposed to be better after September. I guess world events aren't exactly conducive to a stable market. One day something might happen to get the portfolio back on track.